Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | INCB7839 |
| Trade Name | |
| Synonyms | Aderbasib|INCB007839 |
| Drug Descriptions |
INCB7839 (aderbasib) is an inhibitor of ADAM10 and ADAM17, which may indirectly block shedding of ERBB2 (HER2), thereby potentially leading to antitumor activity (PMID: 18757423, PMID: 29230082). |
| DrugClasses | |
| CAS Registry Number | 791828-58-5 |
| NCIT ID | C76115 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| INCB7839 | INCB7839 | 0 | 1 |
| INCB7839 + Rituximab | INCB7839 Rituximab | 0 | 1 |